The expression trends observed in GSE61635 were consistent with those from GSE13887, GSE10325, and clinical samples, with FCER1A downregulated and RGS1 upregulated in SLE patients relative to HCs (Fig. 6). This evidence concerns the gene FCER1A and systemic lupus erythematosus.